Clinical trials recruiting in Lorenskog, Norway

Phase breakdown

Conditions recruiting in Lorenskog, Norway

Recruiting trials in Lorenskog, Norway

• A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
  NCT06925737 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male
• A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
  NCT06227910 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
  NCT06233461 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Lorenskog, Norway?

3 recruiting trials have at least one study site in Lorenskog, Norway.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.